Patient Monitoring Market to Grow at a CAGR of 8.20% Through 2032 - Global Insights, Competitive Landscape, and Forecast | DelveInsight

The patient monitoring market is experiencing steady growth, fueled by the rising incidence of chronic diseases, increased demand for continuous and remote monitoring, and technological advancements in real-time data tracking. Enhanced device features such as wireless connectivity, AI integration, and improved portability are transforming patient care in both hospital and home settings. These developments are expected to drive consistent expansion of the patient monitoring market through 2030.

DelveInsight's Patient Monitoring Market Insights report provides comprehensive market analysis, a detailed competitive landscape, key growth drivers and challenges, and in-depth profiles of leading companies in the patient monitoring market.

Explore the latest trends and growth drivers in the patient monitoring devices Market-download your sample report now https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Key Takeaways from the Patient Monitoring Devices Market Report
• The global patient monitoring devices market was valued at USD 35.21 billion in 2023 and is projected to reach USD 56.46 billion by 2032, growing at a CAGR of 8.20% during the forecast period (2025-2032).
• As per DelveInsight estimates, North America is anticipated to dominate the global patient monitoring market during the forecast period.
• Notable patient monitoring devices companies such as Medtronic plc, GE Healthcare, Philips Healthcare, Abbott Laboratories, Siemens Healthineers, Nihon Kohden Corporation, Masimo Corporation, Omron Healthcare Co., Ltd., Smiths Medical, Hillrom, Welch Allyn, Inc., Natus Medical Incorporated, Mindray Medical International Limited, Nonin Medical, Inc., Spacelabs Healthcare, and several others are currently operating in the patient monitoring market.
• In May 2025, Zynex, Inc. (NASDAQ: ZYXI) announced the submission of a 510(k) application to the FDA for NiCOTM, its noninvasive CO-oximeter device used in patient monitoring.
• In March 2025, Sibel Health announced the closing of $30 million in new equity financing and its 7th FDA 510(k) clearance. The financing, led by the Steele Foundation for Hope and Dräger, will accelerate the commercial deployment of the ANNE® One monitoring platform.
• In November 2024, BioIntelliSense received FDA approval for its BioButton Multi-Patient wearable and BioDashboard system. These innovations are designed to enhance hospital-based virtual care programs and extend patient monitoring into the home, improving continuous care and patient outcomes.
• In October 2024, BioIntelliSense announced the FDA clearance of its rechargeable BioButton® Multi-Patient wearable and BioDashboardTM system. This innovation aims to enhance hospital virtual care programs cost-effectively. The BioButton Multi-Patient device expands BioIntelliSense's award-winning continuous patient monitoring portfolio by providing a rechargeable and reusable solution for automating vital sign collection in various settings, including medical-surgical units, specialty care areas, emergency departments, and home care.

To read more about the latest highlights related to the patient monitoring market, get a snapshot of the key highlights entailed in the global patient monitoring devices market report here https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Patient Monitoring Devices Overview
Patient monitoring devices play a crucial role in tracking vital physiological parameters such as heart rate, blood pressure, oxygen saturation, and respiratory rate, enabling timely clinical decisions. These devices are widely used in hospitals, ambulatory care, and increasingly in home healthcare settings due to the growing need for continuous and remote monitoring. Advancements in wireless technology, AI integration, and compact designs have made modern monitoring systems more efficient, portable, and user-friendly. With the rising burden of chronic diseases and aging populations, the demand for patient monitoring devices continues to surge globally.

Patient Monitoring Devices Market Insights
North America is expected to dominate the patient monitoring market due to the high prevalence of chronic conditions such as respiratory and cardiovascular disorders, alongside a growing elderly population. For instance, CDC data reported a 7.8% asthma prevalence in the U.S. in 2019, while the U.S. Census Bureau noted 52 million people aged 65+ in 2018-both factors driving demand for monitoring solutions.

Additionally, technological advancements, favorable government initiatives for remote monitoring, and active product development by key players support market growth. A notable example includes Boston Scientific's FDA clearance in June 2020 for its LUX-DxTM Insertable Cardiac Monitor. These combined factors are expected to fuel significant growth in the North American patient monitoring devices market through 2032.

To know more about why North America is leading the market growth in the patient monitoring devices market, get a snapshot of the patient monitoring market outlook here https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Patient Monitoring Devices Market Dynamics
The patient monitoring devices market is poised for strong growth due to the rising global burden of chronic diseases such as cardiovascular disorders, diabetes, and cancer. Regular monitoring is critical for effective disease management and preventing complications-for example, glucose monitoring helps diabetic patients maintain blood sugar levels and avoid related issues like kidney and eye diseases. According to the International Diabetes Federation (2021), 537 million adults lived with diabetes globally, with cases expected to reach 643 million by 2030 and 783 million by 2045.

Additionally, the growing adoption of telemedicine and preference for remote patient monitoring are driving demand for advanced monitoring technologies. Manufacturers are increasingly focusing on smart devices integrated with the Internet of Medical Things (IoMT). For instance, Smart Meter launched its iGlucose monitor for gestational diabetes management in 2021, while India's startup Dozee introduced a remote monitoring system for COVID-19 vital signs in 2023. These trends have accelerated market growth, especially during the pandemic.

However, the high cost of patient monitoring devices remains a key challenge that could limit wider adoption globally.

Get a sneak peek at the patient monitoring market dynamics @ https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Coverage: Global
Study Period: 2022 to 2032
Patient Monitoring Devices Market CAGR: ~8.20%
Key Patient Monitoring Devices Companies: Medtronic plc, GE Healthcare, Philips Healthcare, Abbott Laboratories, Siemens Healthineers, Nihon Kohden Corporation, Masimo Corporation, Omron Healthcare Co., Ltd., Smiths Medical, Hillrom, Welch Allyn, Inc., Natus Medical Incorporated, Mindray Medical International Limited, Nonin Medical, Inc., Spacelabs Healthcare, and others.

Patient Monitoring Devices Market Segmentation
Market Segmentation By Devices: Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, and others
Market Segmentation By Application: Cardiology, Neurology, Respiratory, and others.
Market Segmentation By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.

Which MedTech key players in the patient monitoring market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr

Table of Contents
1. Patient Monitoring Devices Market Report Introduction
2. Patient Monitoring Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Patient Monitoring Devices Market Key Factors Analysis
6. Patient Monitoring Devices Market Porter's Five Forces Analysis
7. Patient Monitoring Devices Market Layout
8. Patient Monitoring Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.